Is SBTX or DIVO a better dividend investment in 2026?

SBTX currently yields 34.07% with a 5% 5-year dividend growth rate. DIVO yields 6.62% with 5% growth. The better choice depends on your goal: SBTX offers higher current income.

What is the dividend yield difference between SBTX and DIVO?

SBTX has a forward dividend yield of 34.07% ($2.00/share annually). DIVO yields 6.62% ($2.91/share annually). The yield gap is 27.45 percentage points.

Home › Compare › SBTX vs DIVO

SBTX vs DIVO: Dividend Comparison 2026

SBTX yields 34.07% · DIVO yields 6.62%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SBTX wins by $136.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

SBTX

● Live price

34.07%

Share price

$5.87

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$167.0K

Annual income

$24,647.82

Full SBTX calculator →

DIVO

● Live price

6.62%

Share price

$44.00

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.0K

Annual income

$1,008.47

Full DIVO calculator →

Portfolio growth — SBTX vs DIVO

📍 SBTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SBTX	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SBTX + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SBTX pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBTX

Annual income on $10K today (after 15% tax)

$2,896.08/yr

After 10yr DRIP, annual income (after tax)

$20,950.65/yr

DIVO

Annual income on $10K today (after 15% tax)

$562.67/yr

After 10yr DRIP, annual income (after tax)

$857.20/yr

At 15% tax rate, SBTX beats the other by $20,093.45/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBTX + DIVO for your $10,000?

SBTX: 50%DIVO: 50%

100% DIVO50/50100% SBTX

Portfolio after 10yr

$99.0K

Annual income

$12,828.15/yr

Blended yield

12.96%

📊

Analyst Conviction Gap

Where Wall Street is split right now

SBTX

Analyst Ratings

Hold

Consensus: Hold

Altman Z

-0.3

Piotroski

1/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBTX buys

DIVO buys

No recent congressional trades found for SBTX or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSBTXDIVO

Forward yield	34.07% ✓	6.62%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$167.0K ✓	$31.0K
Annual income after 10y	$24,647.82 ✓	$1,008.47
Total dividends collected	$119.3K ✓	$8.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: SBTX vs DIVO ($10,000, DRIP)

Year	SBTX Portfolio	SBTX Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$14,107	$3,407.16	$11,362	$661.96	+$2.7K → SBTX
2	$19,587	$4,492.08	$12,860	$702.91	+$6.7K → SBTX
3	$26,787	$5,828.90	$14,504	$743.56	+$12.3K → SBTX
4	$36,112	$7,450.06	$16,303	$783.73	+$19.8K → SBTX
5	$48,026	$9,386.56	$18,268	$823.31	+$29.8K → SBTX
6	$63,055	$11,666.79	$20,408	$862.17	+$42.6K → SBTX
7	$81,784	$14,315.54	$22,737	$900.20	+$59.0K → SBTX
8	$104,862	$17,353.02	$25,266	$937.31	+$79.6K → SBTX
9	$132,997	$20,794.11	$28,008	$973.42	+$105.0K → SBTX
10	$166,954	$24,647.82	$30,977	$1,008.47	+$136.0K → SBTX

SBTX vs DIVO: Complete Analysis 2026

SBTX — Stock

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Full SBTX Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this SBTX vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBTX vs SCHD SBTX vs JEPI SBTX vs O SBTX vs KO SBTX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.